Evaluation and integration of cancer gene classifiers: Identification and ranking of plausible drivers

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Liu, Yang ^a   Tian, Feng ^a   Hu, Zhenjun ^a   Delisi, Charles ^a  

^a Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR PROTEIN;

ANIMAL; CLASSIFICATION; GENETIC DATABASE; GENETICS; HUMAN; MACHINE LEARNING; MUTATION; TUMOR GENE; UNITED STATES;

ANIMALS; DATABASES, GENETIC; GENES, NEOPLASM; HUMANS; MACHINE LEARNING; MUTATION; NEOPLASM PROTEINS; UNITED STATES;

EID: 84929153265     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10204     Document Type: Article

References (60)

1. Hanahan, D. & Weinberg, R. A. Hallmarks of Cancer: The Next Generation. Cell 144, 646-674 (2011).
2. Chin, L. et al. Comprehensive genomic characterization defnes human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008).
3. Hudson, T. J. et al. International network of cancer genome projects. Nature 464, 993-998 (2010).
4. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007).
5. Watson, I. R., Takahashi, K., Futreal, P. A. & Chin, L. Emerging patterns of somatic mutations in cancer. Nat. Rev. Genet. 14, 703-718 (2013).
6. Dees, N. D. et al. MuSiC: Identifying mutational signifcance in cancer genomes. Genome. Res. 22, 1589-1598 (2012).
7. Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
8. Youn, A. & Simon, R. Identifying cancer driver genes in tumor genome sequencing studies. Bioinformatics 27, 175-181 (2011).
9. Gonzalez-Perez, A. & Lopez-Bigas, N. Functional impact bias reveals cancer drivers. Nucleic Acids Res. 40, e169 (2012).
10. Tamborero, D., Gonzalez-Perez, A. & Lopez-Bigas, N. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes. Bioinformatics 29, 2238-2244 (2013).
11. Reimand, J. & Bader, G. D. Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers. Mol. Syst. Biol. 10, 5633; DOI:10.15252/msb.20145633 (2014).
12. Linghu, B., Snitkin, E. S., Hu, Z., Xia, Y. & Delisi, C. Genome-wide prioritization of disease genes and identifcation of disease-disease associations from an integrated human functional linkage network. Genome. biology 10, R91; DOI:10.1186/gb-2009-10-9-r91 (2009).
13. Cerami, E., Demir, E., Schultz, N., Taylor, B. S. & Sander, C. Automated Network Analysis Identifes Core Pathways in Glioblastoma. Plos. One 5, e8918; doi:10.1371/journal.pone.0008918 (2010).
14. Ciriello, G., Cerami, E., Sander, C. & Schultz, N. Mutual exclusivity analysis identifes oncogenic network modules. Genome. Res. 22, 398-406 (2012).
15. Vandin, F., Upfal, E. & Raphael, B. J. De novo discovery of mutated driver pathways in cancer. Genome. Res. 22, 375-385 (2012).
16. Liu, Y. & Hu, Z. Identifcation of collaborative driver pathways in breast cancer. BMC genomics 15, 605 (2014).
17. Tamborero, D. et al. Comprehensive identifcation of mutational cancer driver genes across 12 tumor types. Sci. Rep. 3, 2650; DOI:10.1038/srep02650 (2013).
18. Cheng, W. C. et al. DriverDB: an exome sequencing database for cancer driver gene identifcation. Nucleic Acids Res. 42, D1048-D1054 (2014).
19. Noble, W. S. What is a support vector machine? Nat. Biotechnol. 24, 1565-1567 (2006).
20. Liu, Y., Li, M., Cheung, Y. M., Sham, P. C. & Ng, M. K. SKM-SNP: SNP markers detection method. J. Biomed. Inform. 43, 233-239 (2010).
21. Liu, Y. & Ng, M. Shrunken methodology to genome-wide SNPs selection and construction of SNPs networks. BMC systems biology 4 Suppl 2, S5; DOI:10.1186/1752-0509-4-S2-S5 (2010).
22. Wu, Q. Y., Ye, Y. M., Liu, Y. & Ng, M. K. SNP Selection and Classifcation of Genome-Wide SNP Data Using Stratifed Sampling Random Forests. Ieee T Nanobiosci. 11, 216-227 (2012).
23. Golub, T. R. et al. Molecular classifcation of cancer: Class discovery and class prediction by gene expression monitoring. Science 286, 531-537 (1999).
24. Holloway, D. T., Kon, M. A. & DeLisi, C. Machine learning methods for transcription data integration. Ibm. J. Res. Dev. 50, 631-643 (2006).
25. Holloway, D. T., Kon, M. & DeLisi, C. In silico regulatory analysis for exploring human disease progression. Biology direct 3, 24; DOI:10.1186/1745-6150-3-24 (2008).
26. Koboldt, D. C. et al. Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70 (2012).
27. Bell, D. et al. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609-615 (2011).
28. An, O. et al. NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes. Database 2014, bau015; DOI:10.1093/database/bau015 (2014).
29. Welter, D. et al. The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42, D1001-1006 (2014).
30. Becker, K. G., Barnes, K. C., Bright, T. J. & Wang, S. A. The genetic association database. Nature genetics 36, 431-432 (2004).
31. Melville, P. & Mooney, R. J. Creating Diversity in Ensembles Using Artifcial Data. Information Fusion: Special Issue on Diversity in Multiclassifer Systems 6, 99-111 (2004).
32. Huang, D. W., Sherman, B. T. & Lempicki, R. A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37, 1-13 (2009).
33. Hu, Z. et al. VisANT 4.0: Integrative network platform to connect genes, drugs, diseases and therapies. Nucleic Acids Res. 41, W225-231 (2013).
34. Vogelstein, B. et al. Cancer Genome Landscapes. Science 339, 1546-1558 (2013).
35. D'Antonio, M. & Ciccarelli, F. D. Integrated analysis of recurrent properties of cancer genes to identify novel drivers. Genome. biology 14, R52; DOI:10.1186/gb-2013-14-5-r52 (2013).
36. Belguise, K. et al. The PKCtheta pathway participates in the aberrant accumulation of Fra-1 protein in invasive ER-negative breast cancer cells. Oncogene 31, 4889-4897 (2012).
37. Craig, D. W. et al. Genome and Transcriptome Sequencing in Prospective Metastatic Triple-Negative Breast Cancer Uncovers Terapeutic Vulnerabilities. Mol. Cancer Ter. 12, 104-116 (2013).
38. Zhang, Y. et al. Expression of breast cancer metastasis suppressor-1, BRMS-1, in human breast cancer and the biological impact of BRMS-1 on the migration of breast cancer cells. Anticancer research 34, 1417-1426 (2014).
39. Chimonidou, M., Kallergi, G., Georgoulias, V., Welch, D. R. & Lianidou, E. S. Breast cancer metastasis suppressor-1 promoter methylation in primary breast tumors and corresponding circulating tumor cells. Molecular cancer research: MCR 11, 1248-1257 (2013).
40. Hernandez-Vargas, H. et al. Methylome analysis reveals Jak-STAT pathway deregulation in putative breast cancer stem cells. Epigenetics-Us 6, 429-440 (2011).
41. Giampieri, S. et al. Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility. Nature cell biology 11, 1287-1296 (2009).
42. Caldon, C. E., Daly, R. J., Sutherland, R. L. & Musgrove, E. A. Cell cycle control in breast cancer cells. Journal of cellular biochemistry 97, 261-274 (2006).
43. Bertocchi, C., Vaman Rao, M. & Zaidel-Bar, R. Regulation of adherens junction dynamics by phosphorylation switches. Journal of signal transduction 2012, 125295; DOI:10.1155/2012/125295 (2012).
44. Lazaro, G. et al. Targeting focal adhesion kinase in ER+/HER2+ breast cancer improves trastuzumab response. Endocrine-related cancer 20, 691-704 (2013).
45. Standish, L. J. et al. Breast cancer and the immune system. Journal of the Society for Integrative Oncology 6, 158-168 (2008).
46. Campbell, M. J., Scott, J., Maecker, H. T., Park, J. W. & Esserman, L. J. Immune dysfunction and micrometastases in women with breast cancer. Breast Cancer Res. Tr. 91, 163-171 (2005).
47. Hondermarck, H. Neurotrophins and their receptors in breast cancer. Cytokine Growth F R 23, 357-365 (2012).
48. Louie, E. et al. Neurotrophin-3 modulates breast cancer cells and the microenvironment to promote the growth of breast cancer brain metastasis. Oncogene 32, 4064-4077 (2013).
49. Yadav, V. & Denning, M. F. Fyn Is Induced by Ras/PI3K/Akt Signaling and Is Required for Enhanced Invasion/Migration. Mol. Carcinogen 50, 346-352 (2011).
50. Cance, W. G. & Liu, E. T. Protein-Kinases in Human Breast-Cancer. Breast Cancer Res. Tr. 35, 105-114 (1995).
51. Zou, Z. et al. PKD2 and PKD3 promote prostate cancer cell invasion by modulating NF-kappaB-and HDAC1-mediated expression and activation of uPA. Journal of cell science 125, 4800-4811 (2012).
52. Davis, S. J. et al. Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer. Bmc Cancer 11, 173; DOI:10.1186/1471-2407-11-173 (2011).
53. Denkert, C. et al. Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma. Int. J. Cancer 102, 507-513 (2002).
54. Hall, M. et al. The WEKA Data Mining Sofware: An Update. SIGKDD Explorations 11, 10-18 (2009).
55. John, G. H. & Langley, P. Estimating Continuous Distributions in Bayesian Classifers. In Proceedings of the Eleventh Conference on Uncertainty in Artifcial Intelligence: Montreal, Quebec. (Morgan Kaufmann Publishers Inc. San Francisco, CA, USA,. 338-345 (1995 Aug 18).
56. Platt J. C. Fast training of support vector machines using sequential minimal optimization in Advances in kernel methods-Support Vector Learning (eds Schoelkopf, B. et al.) 185-208 (MIT Press, 1998).
57. Quinlan, R. C4.5: Programs for Machine Learning in Quinlan1993 (Morgan Kaufmann Publishers, 1993).
58. Breiman, L. Random Forests. Machine Learning 45, 5-32 (2001).
59. Breiman, L. Bagging predictors. Machine Learning 24, 123-140 (1996).
60. Freund, Y. & Schapire, R. E. Experiments with a new boosting algorithm. In Proceedings of the Tirteenth International Conference on Machine Learning: Bari, Italy. Morgan Kaufmann Publishers Inc. San Francisco, CA, USA. 148-156 (1996 July).